CSX vs NYR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CSX

CLEANSPACE FPO [CSX]

52MEDIUM

NYR

NYRADA CDI FORUS [NYR]

52MEDIUM

Score Breakdown

CSX NYR
Technical
59
72
Catalyst
50
53
Sentiment
50
50
Fundamental
95
38
Momentum
59
71
Risk Gate
47
42

Key Metrics

CSX Metric NYR
$38.2MMarket Cap$134.7M
15KAvg Volume (20d)545K
N/AShort InterestN/A
$0.88052-Week High$1.435
$0.37052-Week Low$0.091
+0.0%Daily Change+16.9%
$0.465Entry Price$0.567
+8.8%ROE-71.0%
+8.5%Profit Margin-234.3%

Active Signals

CSX Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●MACD just crossed bullish — momentum is shifting to the upside
●Trading below both moving averages — the trend is working against this one
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.8x)
●Moderate revenue growth (+10%)

NYR Signals

●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●On a tear — up 12.3% over the last 5 days
●Trading above the 200-day average — the long-term trend is on your side
●Low cash runway (4 quarters) - dilution risk
●Very high P/S ratio (56.6x)
●Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare CSX and NYR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CSX Full Analysis → NYR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).